EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR TREATMENT FOR 8 WEEKS IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION WITHOUT CIRRHOSIS OR WITH COMPENSATED CIRRHOSIS: ANALYSIS OF DATA POOLED FROM PHASE 2 AND 3 STUDIES
Publication
, Conference
Gutierrez, J; Zuckerman, E; Ustianowski, A; Naggie, S; Caruntu, F; Ravendhran, N; Sigal, S; Barrett, L; Cohen, SM; Crown, E; Dylla, D; Wang, S ...
Published in: GASTROENTEROLOGY
May 1, 2019
Duke Scholars
Published In
GASTROENTEROLOGY
EISSN
1528-0012
ISSN
0016-5085
Publication Date
May 1, 2019
Volume
156
Issue
6
Start / End Page
S1218 / S1218
Location
San Diego, CA
Publisher
W B SAUNDERS CO-ELSEVIER INC
Conference Name
Digestive Disease Week (DDW)
Related Subject Headings
- Gastroenterology & Hepatology
- 3210 Nutrition and dietetics
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gutierrez, J., Zuckerman, E., Ustianowski, A., Naggie, S., Caruntu, F., Ravendhran, N., … Bruno, S. (2019). EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR TREATMENT FOR 8 WEEKS IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION WITHOUT CIRRHOSIS OR WITH COMPENSATED CIRRHOSIS: ANALYSIS OF DATA POOLED FROM PHASE 2 AND 3 STUDIES. In GASTROENTEROLOGY (Vol. 156, pp. S1218–S1218). San Diego, CA: W B SAUNDERS CO-ELSEVIER INC.
Gutierrez, Julio, Eli Zuckerman, Andrew Ustianowski, Susanna Naggie, Florin Caruntu, Natarajan Ravendhran, Samuel Sigal, et al. “EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR TREATMENT FOR 8 WEEKS IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION WITHOUT CIRRHOSIS OR WITH COMPENSATED CIRRHOSIS: ANALYSIS OF DATA POOLED FROM PHASE 2 AND 3 STUDIES.” In GASTROENTEROLOGY, 156:S1218–S1218. W B SAUNDERS CO-ELSEVIER INC, 2019.
Gutierrez J, Zuckerman E, Ustianowski A, Naggie S, Caruntu F, Ravendhran N, et al. EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR TREATMENT FOR 8 WEEKS IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION WITHOUT CIRRHOSIS OR WITH COMPENSATED CIRRHOSIS: ANALYSIS OF DATA POOLED FROM PHASE 2 AND 3 STUDIES. In: GASTROENTEROLOGY. W B SAUNDERS CO-ELSEVIER INC; 2019. p. S1218–S1218.
Gutierrez, Julio, et al. “EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR TREATMENT FOR 8 WEEKS IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION WITHOUT CIRRHOSIS OR WITH COMPENSATED CIRRHOSIS: ANALYSIS OF DATA POOLED FROM PHASE 2 AND 3 STUDIES.” GASTROENTEROLOGY, vol. 156, no. 6, W B SAUNDERS CO-ELSEVIER INC, 2019, pp. S1218–S1218.
Gutierrez J, Zuckerman E, Ustianowski A, Naggie S, Caruntu F, Ravendhran N, Sigal S, Barrett L, Cohen SM, Crown E, Dylla D, Fredrick L, Wang S, Porcalla AR, Mensa F, Bruno S. EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR TREATMENT FOR 8 WEEKS IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION WITHOUT CIRRHOSIS OR WITH COMPENSATED CIRRHOSIS: ANALYSIS OF DATA POOLED FROM PHASE 2 AND 3 STUDIES. GASTROENTEROLOGY. W B SAUNDERS CO-ELSEVIER INC; 2019. p. S1218–S1218.
Published In
GASTROENTEROLOGY
EISSN
1528-0012
ISSN
0016-5085
Publication Date
May 1, 2019
Volume
156
Issue
6
Start / End Page
S1218 / S1218
Location
San Diego, CA
Publisher
W B SAUNDERS CO-ELSEVIER INC
Conference Name
Digestive Disease Week (DDW)
Related Subject Headings
- Gastroenterology & Hepatology
- 3210 Nutrition and dietetics
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1109 Neurosciences
- 1103 Clinical Sciences